Pharma Market Access Insights - from Petauri Evidence
By Petauri Evidence
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Petauri Evidence
Category: Life Sciences
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 0
Reviews: 0
Episodes: 67
Description
We explore news and insights from global healthcare markets, advising how pharma and medtech need to respond and adapt their market access strategy in light of the latest insights from our experts. The podcast features insights from our associates across global healthcare, along with thought leadership from the market access and HEOR experts at Petauri Evidence.
| Episode | Date |
|---|---|
|
Communicating value to US Payers: Insights for Pharma and Medtech
|
Apr 29, 2025 |
|
Navigating market access: Launch strategies and health economic modelling for medical devices
|
Apr 24, 2025 |
|
Navigating US payer evidence needs to optimise market access
|
Nov 27, 2024 |
|
Best practice RWE approaches to support economic modelling for HTA
|
Nov 20, 2024 |
|
NHS winter planning 2024–25 – Engaging with NHS decision-makers through Autumn to Christmas
|
Nov 18, 2024 |
|
De-mystifying the NHS – What you need to know about the NHS as a market for your health technology
|
Oct 11, 2024 |
|
NHS primary care panel – the GP Contract and Operational Planning Guidance
|
Sep 10, 2024 |
|
Engage NHS healthcare decision-makers with RWD
|
Aug 12, 2024 |
|
Market access and reimbursement in Canada – changes at CADTH
|
Jun 20, 2024 |
|
Rare Disease market access in the MENA and Nordic regions
|
May 10, 2024 |
|
How does funding flow in NHSE Regions?
|
Apr 09, 2024 |
|
NHS policy for 2024/25: strategy and engagement in a world of uncertainty (recorded in Jan 2024)
|
Apr 09, 2024 |
|
De-mystifying health economic model classifications and structures
|
Mar 22, 2024 |
|
Evidence strategy for Medical Technologies and Diagnostics
|
Mar 12, 2024 |
|
How to set your Pharma or Medtech product up for success in the US market
|
Feb 26, 2024 |
|
What's happening with specialised commissioning in the NHS?
|
Feb 12, 2024 |
|
Integrated care in NHS Wales – what can England learn from its neighbour?
|
Jan 17, 2024 |
|
Market access in Italy: Reforms at AIFA
|
Dec 18, 2023 |
|
Unmet need in NHS primary care – How can industry best support PCN leaders?
|
Nov 28, 2023 |
|
Population health management: a community effort across health and life sciences
|
Nov 01, 2023 |
|
Artificial intelligence (AI) in clinical trials: Implications for evidence synthesis and market access
|
Oct 26, 2023 |
|
6 areas of UK health policy for Medtech to pay attention to
|
Oct 16, 2023 |
|
Market access in the German speaking markets
|
Aug 29, 2023 |
|
The role of nursing in driving digital change in the NHS
|
Jul 26, 2023 |
|
Market access for digital therapies and digital medicines
|
Jul 19, 2023 |
|
A global market access journey in cannabinoid pharmaceuticals
|
Jun 17, 2023 |
|
Primary Care and ICBs – what is the next step in the integration journey?
|
May 15, 2023 |
|
Data-led transformation in the NHS - partnering to optimise patient care
|
Mar 31, 2023 |
|
Innovating for better health – research, collaboration and innovation in the NHS
|
Mar 07, 2023 |
|
Healthcare, economics and society – unlocking NHS collaboration
|
Jan 30, 2023 |
|
Specialised Commissioning in the NHS – What do you need to know now
|
Jan 13, 2023 |
|
Why are we waiting? - Pressures facing the NHS and how to deliver change
|
Nov 29, 2022 |
|
Priority setting in primary care - NHS insights
|
Oct 18, 2022 |
|
Integrated Care Systems go live in the NHS - reflections after 3 weeks
|
Aug 09, 2022 |
|
Clinical Pharmacists – exploring the scope, capabilities, and potential of this evolving NHS role
|
Aug 01, 2022 |
|
Transforming systems and care pathways for an integrated NHS
|
Jun 21, 2022 |
|
Digital value payer communication tools: How to meet the needs of your internal stakeholders and customers
|
May 04, 2022 |
|
Population to Person: How will the NHS translate population health management into impactful, person-centred service change?
|
Mar 15, 2022 |
|
Planning in a volatile environment: how will the NHS reconcile its competing priorities and operational planning to meet its challenges?
|
Feb 11, 2022 |
|
The evolving NHS: How can Pharma and Medtech support the NHS in 2022? - NHS Insights Panel Discussion
|
Jan 17, 2022 |
|
Optimising the NHS – How will medicines be valued in integrated systems?
|
Dec 21, 2021 |
|
Rare disease market access - strategic and tactical challenges facing orphan medicines entering Europe
|
Nov 29, 2021 |
|
A new paradigm for the NHS: Partnering to deliver lasting and meaningful care improvements - with Dr Phil Webb (Chief Executive of Respiratory Innovation Wales)
|
Oct 01, 2021 |
|
Innovations to address health inequalities in the NHS and how Pharma and Medtech can help
|
Sep 10, 2021 |
|
The hidden heroes of the NHS - The role of ambulance Trusts in keeping patients and systems moving
|
Jul 06, 2021 |
|
Population to person - How will the voice of the individual drive health and care development?
|
Jun 02, 2021 |
|
Know your Place - where will power really sit in the new NHS - with Dr Steven Michael OBE
|
May 17, 2021 |
|
Health Economic Modelling for MedTech Innovation - What, Why and How
|
Apr 14, 2021 |
|
Pharmacy, Medicines, and Specialised Commissioning in the new NHS
|
Apr 12, 2021 |
|
The White Paper and integrated care in the NHS: What it really means in practice for clinicians, patients and us - with Dr John Ribchester
|
Mar 11, 2021 |
|
Heads at the heart of the NHS: How mental health is central to everything in the new NHS - with Brent Kilmurray (Chief Executive of Tees, Esk and Wear Valleys NHS Foundation Trust)
|
Feb 05, 2021 |
|
Pharmacy and Medicines in the Integrated Care Systems (ICS) of the new NHS with Laura Angus
|
Jan 13, 2021 |
|
Is prevention better than the cure? How can the NHS and public health work closer to improve population health?
|
Nov 27, 2020 |
|
Understanding the tipping point: When elective becomes selective in NHS surgery
|
Nov 16, 2020 |
|
Leading within an evolving, integrating system: insights from an NHS leader
|
Oct 21, 2020 |
|
Integrated Care Systems: Separating fact from myth – insights from a system leader
|
Oct 15, 2020 |
|
The Evolving NHS - Lessons for Pharma and Medtech - NHS insights webinar with David Thorne and Tom Clarke
|
Oct 09, 2020 |
|
The Role of the Independent Sector, Post-COVID with Jim Easton (CEO of Care UK)
|
Aug 11, 2020 |
|
The Tech Perspective with Stephen Bourke (Co-Founder of Echo, The Online Pharmacy)
|
Aug 05, 2020 |
|
Questions Time Special - Views from across the NHS; from costings to strategy to clinical care
|
Jul 30, 2020 |
|
The Changing Face of Care Delivery Part 2: The Primary Care & Community View with Steve Reed (Head of Community Services, York Teaching Hospitals NHS FT) and Dr John Ribchester (PCN Clinical Director, GP and Chair of Encompass GP Partnership, Whitstable)
|
Jul 20, 2020 |
|
The Changing Face of Care Delivery Part 1: The System & Hospital View with Berenice Groves (Director of Operations, Blackpool Teaching Hospitals NHS FT) and Tina Teague (COVID Resilience Manager for Devon)
|
Jul 14, 2020 |
|
Strategic Procurement & Medicines Management with Keith Pearson (Head of Medicines Optimisation, in a CCG) and Simon Wootton (Non Exec Director, in a PCN)
|
Jun 22, 2020 |
|
Pharmacy & Medicines Management with Samantha O’Connell (GP Clinical Pharmacist) and Johnathan Laird (Prescribing Pharmacist)
|
Jun 19, 2020 |
|
Finance & Commissioning with Patrick McGinley (Head of Costings and SLR) and Patricia Whelan-Moss (Head of Organisational Development for a CCG)
|
Jun 18, 2020 |
|
Primary Care & Community Settings with Liz Cross (Advanced Nurse Practitioner) & Dr Su McCole (GP & Area Clinical Director)
|
Jun 09, 2020 |
|
Introductory overview with PCN lead Hilary Snowdon & Secondary Care Chief Exec Mike Proctor
|
Jun 02, 2020 |